Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:2537294.
doi: 10.1155/2016/2537294. Epub 2016 Feb 18.

Modes of Antiviral Action of Chemical Portions and Constituents from Woad Root Extract against Influenza Virus A FM1

Affiliations
Free PMC article

Modes of Antiviral Action of Chemical Portions and Constituents from Woad Root Extract against Influenza Virus A FM1

Jia-Hang Su et al. Evid Based Complement Alternat Med. 2016.
Free PMC article

Expression of concern in

Abstract

Woad root has been used for the prevention of influenza for hundreds of years in many Asian countries. In this study, the antiviral modes of clemastanin B (CB), epigoitrin, phenylpropanoid portion (PEP), and the mixture of phenylpropanoids, alkaloids, and organic acid portions (PEP + ALK + OA) from wood root extract against influenza virus A FM1 were investigated. The results revealed that CB, epigoitrin, PEP, and PEP + ALK + OA exert their anti-influenza activity via inhibiting the virus multiplication, prophylaxis, and blocking the virus attachment. The primary mode of action of PEP and PEP + ALK + OA is the inhibition of virus replication. The inhibitory effect on virus attachment and multiplication is the main modes for epigoitrin. All the compounds or chemical portions from woad root extract tested in this study do not have direct virucidal activity. Our results provided the comprehensive analysis of the antiviral mechanism of wood root extract.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structure of clemastanin B (CB) and epigoitrin.
Figure 2
Figure 2
Effect of different dilutions of pure compounds and chemical portions from woad root on the viability of MDCK cells preinfected with 100 TCID50 of influenza A H1N1 virus: (a) microscopic analysis; (b) MTT assay; (c) cell protection rate (%). CB: clemastanin B; PEP + ALK + OA: the mixtures of phenylpropanoids, alkaloids, and organic acid portions. Cell control: normal MDCK cells without virus infection and drugs treatment; virus control: cells infected with the virus without drug treatments. Ribavirin (1 : 4): error bars represent standard deviation. The asterisks indicate a significant difference between the test samples and the virus control according to Student's t-test.
Figure 3
Figure 3
Direct virucidal effect of pure compounds and chemical portions from woad root extract on influenza A1 virus FM1: (a) cell control; (b) virus control; (c) CB (1 : 2); (d) epigoitrin; (e) PEP (1 : 2); (f) PEP + ALK + OA (1 : 2); (g) ribavirin (1 : 4).
Figure 4
Figure 4
Differences on the major modes of antiviral action in the pure compounds and chemical portions from woad root extract. A1: therapeutic action; A2: prophylaxis; A3: inhibition of virus attachment. CB: clemastanin B; PEP + ALK + OA: the mixtures of phenylpropanoids, alkaloids, and organic acid portions. The concentration for CB: A1 (1 : 4 dilution), A2 (1 : 8 dilution), and A3 (1 : 2 dilution); epigoitrin concentration: A1 (1 : 4), A2 (1 : 16), and A3 (1 : 2); PEP + ALK + OA concentration: A1 (1 : 4), A2 (1 : 2), and A3 (1 : 4); PEP concentration: A1 (1 : 8), A2 (1 : 2), and A3 (1 : 2).

Similar articles

Cited by

References

    1. Dawood F. S., Jain S., Finelli L., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. The New England Journal of Medicine. 2009;360(25):2605–2615. doi: 10.1056/nejmoa0903810. - DOI - PubMed
    1. Bacon T. H., Levin M. J., Leary J. J., Sarisky R. T., Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clinical Microbiology Reviews. 2003;16(1):114–128. doi: 10.1128/cmr.16.1.114-128.2003. - DOI - PMC - PubMed
    1. Ludwig S. Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. Journal of Antimicrobial Chemotherapy. 2009;64(1):1–4. doi: 10.1093/jac/dkp161. - DOI - PubMed
    1. Wang X., Jia W., Zhao A., Wang X. Anti-influenza agents from plants and traditional Chinese medicine. Phytotherapy Research. 2006;20(5):335–341. doi: 10.1002/ptr.1892. - DOI - PubMed
    1. Wang Z., Zhu Y. Anti-respiratory passage virus of Chinese herbal medicine. Health. 2010;2(12):1397–1400. doi: 10.4236/health.2010.212207. - DOI

LinkOut - more resources